The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells

Introduction. Glioblastoma is the most malignant brain tumor with different therapeutic protocols, including surgery, radiotherapy, and chemotherapy. Substance P (SP), a peptide released by sensory nerves, increases cellular excitability by activating the neurokinin-1 receptor (NK1R) in several huma...

Full description

Saved in:
Bibliographic Details
Main Authors: Faranak Korfi, Hossein Javid, Reza Assaran Darban, Seyed Isaac Hashemy
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Biochemistry Research International
Online Access:http://dx.doi.org/10.1155/2021/6620708
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547771233599488
author Faranak Korfi
Hossein Javid
Reza Assaran Darban
Seyed Isaac Hashemy
author_facet Faranak Korfi
Hossein Javid
Reza Assaran Darban
Seyed Isaac Hashemy
author_sort Faranak Korfi
collection DOAJ
description Introduction. Glioblastoma is the most malignant brain tumor with different therapeutic protocols, including surgery, radiotherapy, and chemotherapy. Substance P (SP), a peptide released by sensory nerves, increases cellular excitability by activating the neurokinin-1 receptor (NK1R) in several human tumor cells. Aprepitant is a potent and long-lasting NK1R antagonist, considered a new agent for inhibiting proliferation and induction of apoptosis in malignant cells. This study aimed to evaluate the effects of the SP/NK1R system on the expression and activity of catalase and superoxide dismutase (SOD) in the glioblastoma U87 cancer cell line. Methods. Cytotoxicity was measured by the resazurin test, 24 hours after treatment, with increasing aprepitant concentrations. The production of reactive oxygen species (ROS) was also measured 24 hours after treatment with SP and aprepitant. Enzymes activity of catalase and SOD was measured using the corresponding assay kits. Real-time PCR also measured their expression. Results. Aprepitant significantly reduced the viability of U87 cells in a concentration-dependent manner. ROS production was significantly reduced, and the activity of catalase and SOD increased after treatment with aprepitant. The expression of catalase and SOD enzymes also increased significantly in the presence of aprepitant. Conclusion. The present study showed that aprepitant inhibited SP’s oxidizing effects via inducing the antioxidant effects of catalase and SOD in the U87 cell line. Therefore, this drug might be introduced as a potential candidate for controlling glioblastoma cancer in animal models and clinical trials.
format Article
id doaj-art-4072ee401c0640029499c6f4ec3dd202
institution Kabale University
issn 2090-2247
2090-2255
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Biochemistry Research International
spelling doaj-art-4072ee401c0640029499c6f4ec3dd2022025-02-03T06:43:29ZengWileyBiochemistry Research International2090-22472090-22552021-01-01202110.1155/2021/66207086620708The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer CellsFaranak Korfi0Hossein Javid1Reza Assaran Darban2Seyed Isaac Hashemy3Department of Biology, Faculty of Sciences, Islamic Azad University of Mashhad, Mashhad, IranDepartment of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Biology, Faculty of Sciences, Islamic Azad University of Mashhad, Mashhad, IranDepartment of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranIntroduction. Glioblastoma is the most malignant brain tumor with different therapeutic protocols, including surgery, radiotherapy, and chemotherapy. Substance P (SP), a peptide released by sensory nerves, increases cellular excitability by activating the neurokinin-1 receptor (NK1R) in several human tumor cells. Aprepitant is a potent and long-lasting NK1R antagonist, considered a new agent for inhibiting proliferation and induction of apoptosis in malignant cells. This study aimed to evaluate the effects of the SP/NK1R system on the expression and activity of catalase and superoxide dismutase (SOD) in the glioblastoma U87 cancer cell line. Methods. Cytotoxicity was measured by the resazurin test, 24 hours after treatment, with increasing aprepitant concentrations. The production of reactive oxygen species (ROS) was also measured 24 hours after treatment with SP and aprepitant. Enzymes activity of catalase and SOD was measured using the corresponding assay kits. Real-time PCR also measured their expression. Results. Aprepitant significantly reduced the viability of U87 cells in a concentration-dependent manner. ROS production was significantly reduced, and the activity of catalase and SOD increased after treatment with aprepitant. The expression of catalase and SOD enzymes also increased significantly in the presence of aprepitant. Conclusion. The present study showed that aprepitant inhibited SP’s oxidizing effects via inducing the antioxidant effects of catalase and SOD in the U87 cell line. Therefore, this drug might be introduced as a potential candidate for controlling glioblastoma cancer in animal models and clinical trials.http://dx.doi.org/10.1155/2021/6620708
spellingShingle Faranak Korfi
Hossein Javid
Reza Assaran Darban
Seyed Isaac Hashemy
The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
Biochemistry Research International
title The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
title_full The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
title_fullStr The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
title_full_unstemmed The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
title_short The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
title_sort effect of sp nk1r on the expression and activity of catalase and superoxide dismutase in glioblastoma cancer cells
url http://dx.doi.org/10.1155/2021/6620708
work_keys_str_mv AT faranakkorfi theeffectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT hosseinjavid theeffectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT rezaassarandarban theeffectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT seyedisaachashemy theeffectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT faranakkorfi effectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT hosseinjavid effectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT rezaassarandarban effectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells
AT seyedisaachashemy effectofspnk1rontheexpressionandactivityofcatalaseandsuperoxidedismutaseinglioblastomacancercells